Optimizing and de-risking preclinical development.

Fast tracking success.

Headquartered in Melbourne, Australia, Minotaur Pharma provides consulting services to global early-stage drug and device development startups. We specialize in whole of lifecycle pre-clinical development across all therapeutic domains, including: strategic and commercial targeting of indications (TPPs); go/no-go and gap analyses, nonclinical study design and AEC/IAUCUC approvals; proof of concept through to non-GLP/GLP IND-submission enabling study management; regulatory affairs advice and representation, bid defense and supplier management.

We take promising candidate therapeutics from discovery to Phase 1 and beyond.

Wherever you are in your development , we optimize your chances of success in human clinical trials, de-risking and fast tracking your journey, and can identify and access alternate markets making you revenue positive, earlier. Co-development of therapies in veterinary markets, to de-risk and diversify portfolios is a key specialty.

We bring extensive human and veterinary clinical, research and industry experience to every project, and customize our support for your individual project’s requirements.

Success - making a difference - with speed, is our mission.

Contact us for an obligation free consultation:

enquiries@minotaurpharma.com